EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel genomic prognostic biomarkers for dogs with cancer

Esther Chon iD, Sharadha Sakthikumar, Min Tang, Matthew J Hamilton, Andrew Vaughan, Ashley Smith, Breann Sommer, Cecilia Robat, Christina Manley, Christine Mullin, Emi Ohashi, Emily Manor und 11 weitere

Journal of Veterinary Internal Medicine · 2023

DOI: 10.1111/jvim.16893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Esther Chon und 22 weiteren Autor:innen. Beteiligte Einrichtung: Vidium Animal Health, A Subsidiary of The Translational Genomics Research Institute (TGen), Scottsdale, Arizona, USA. Hauptthemen laut MEDLINE: Neoplasms, Dog Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Growing evidence from dogs and humans supports the abundance of mutation-based biomarkers in tumors of dogs. Increasing the use of clinical genomic diagnostic testing now provides another powerful data source for biomarker discovery. Hypothesis Analyzed clinical outcomes in dogs with cancer profiled using SearchLight DNA, a cancer gene panel for dogs, to identify mutations with prognostic value. Animals A total of 127 cases of cancer in dogs were analyzed using SearchLight DNA and for which clinical outcome information was available.

Methods

Clinical data points were collected by medical record review. Variables including mutated genes, mutations, signalment, and treatment were fitted using Cox proportional hazard models to identify factors associated with progression-free survival (PFS). The log-rank test was used to compare PFS between patients receiving and not receiving targeted treatment before first progression.

Results

Combined genomic and outcomes analysis identified 336 unique mutations in 89 genes across 26 cancer types. Mutations in 6 genes (CCND1, CCND3, SMARCB1, FANCG, CDKN2A/B, and MSH6) were significantly associated with shorter PFS. Dogs that received targeted treatment before first progression (n = 45) experienced significantly longer PFS compared with those that did not (n = 82, P = .01). This significance held true for 29 dogs that received genomically informed targeted treatment compared with those that did not (P = .05). Conclusion and Clinical Importance We identified novel mutations with prognostic value and demonstrate the benefit of targeted treatment across multiple cancer types. These results provide clinical evidence of the potential for genomics and precision medicine in dogs with cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDog DiseasesHumansDogsAnimalsPrognosisProgression-Free SurvivalMutationGenomicsDNABiomarkers, Tumor

Stichwörter der Autor:innen

doggenesmutationsoutcomesprecision medicineprogression-free survivalreal-worldtargeted therapy

Substanzen

DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Vidium Animal Health, A Subsidiary of The Translational Genomics Research Institute (TGen), Scottsdale, Arizona, USA.
  • STATBEYOND Consulting LLC, Irvine, California, USA.
  • Private Veterinary Specialties, Lebanon, New Jersey, USA.
  • Las Vegas Veterinary Specialty Center, Las Vegas, Nevada, USA.
  • Department of Clinical Sciences, Auburn University College of Veterinary Medicine, Auburn, Alabama, USA.
  • Wisconsin Veterinary Referral Center by Ethos, Waukesha, Wisconsin, USA.

ORCID-Profile: Esther Chon, Kai Biu Shiu, Guannan Wang

Zitieren

APA

Chon, E., Sakthikumar, S., Tang, M., Hamilton, M. J., Vaughan, A., Smith, A., Sommer, B., Robat, C., Manley, C., Mullin, C., Ohashi, E., Manor, E., Custis, J., Intile, J., Shiu, K. B., Parshley, L., Bergman, N., Sheppard-Olivares, S., Hafeman, S., …, & Wang, G. (2023). Novel genomic prognostic biomarkers for dogs with cancer. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16893

Vancouver

Chon E, Sakthikumar S, Tang M, Hamilton MJ, Vaughan A, Smith A, et al. Novel genomic prognostic biomarkers for dogs with cancer. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16893

BibTeX
@article{Chon2023,
  author = {Chon, Esther and Sakthikumar, Sharadha and Tang, Min and Hamilton, Matthew J and Vaughan, Andrew and Smith, Ashley and Sommer, Breann and Robat, Cecilia and Manley, Christina and Mullin, Christine and Ohashi, Emi and Manor, Emily and Custis, James and Intile, Joanne and Shiu, Kai Biu and Parshley, Lisa and Bergman, Noelle and Sheppard-Olivares, Sabina and Hafeman, Scott and Wright, Zachary and Haworth, David and Hendricks, William and Wang, Guannan},
  title = {Novel genomic prognostic biomarkers for dogs with cancer},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  doi = {10.1111/jvim.16893}
}
Kostenlos starten →